Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK, PD, and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05661916
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALN-TTRSC04 in Healthy Subjects

Who this might be right for
Transthyretin-Mediated Amyloidosis
Alnylam Pharmaceuticals 96
Early research (Phase 1)Study completedNCT01925521
What this trial is testing

OPS-2071 Single and Multiple Dose Study to Investigate PK and PD Profile in Healthy Korean Male Subjects.

Who this might be right for
Healthy
Korea Otsuka Pharmaceutical Co., Ltd. 96
Early research (Phase 1)Study completedNCT05481307
What this trial is testing

Evaluate Pharmacokinetic/Pharmacodynamic Drug-drug Interaction and Safety/Tolerability Between RLD2202 and RLD2203

Who this might be right for
Healthy
Hanmi Pharmaceutical Company Limited 24
Early research (Phase 1)Study completedNCT00462761
What this trial is testing

A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status

Who this might be right for
Acute Myeloid LeukemiaLeukemiaMyelodysplastic Syndrome+2 more
Daiichi Sankyo 76
Early research (Phase 1)Study completedNCT05745883
What this trial is testing

Study of DISC-0974 to Assess the Safety, Tolerability, PK and PD of DISC-0974 in Participants With CKD and Anemia

Who this might be right for
Chronic Kidney DiseasesAnemia of Chronic Kidney Disease
Disc Medicine, Inc 55
Early research (Phase 1)Study completedNCT04606602
What this trial is testing

Study to Investigate Safety, Tolerability, PK and PD Response of SLN360 in Subjects With Elevated Lipoprotein(a)

Who this might be right for
HyperlipidemiasDyslipidemiasElevated Lp(a)
Silence Therapeutics plc 70
Early research (Phase 1)Study completedNCT03443895
What this trial is testing

Multiple Ascending Dose to Study the Safety, Tolerability, PK and PD Effects of AEF0117

Who this might be right for
Healthy Volunteers
Aelis Farma 24
Early research (Phase 1)UnknownNCT05149027
What this trial is testing

Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combine With Toripalimab in Patients With Advanced HCC and Other Solid Tumors

Who this might be right for
Solid Tumors
Harbour BioMed (Guangzhou) Co. Ltd. 67
Early research (Phase 1)Study completedNCT01494636
What this trial is testing

The Safety, Tolerability, PK and PD of GSK2339345 in Healthy Subjects

Who this might be right for
Cough
GlaxoSmithKline 31
Early research (Phase 1)Study completedNCT06725992
What this trial is testing

Study to Evaluate Pharmacokinetic and Pharmacodynamic Drug Interactions and Safety of IY-NS250 and IY-NT-SR

Who this might be right for
PharmacokineticsPharmacodynamics
Il-Yang Pharm. Co., Ltd. 56
Large-scale testing (Phase 3)Active Not RecruitingNCT06724809
What this trial is testing

Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSD

Who this might be right for
NMOSDNeuromyelitis Optica Spectrum Disorders
Alexion Pharmaceuticals, Inc. 21
Early research (Phase 1)Study completedNCT03959514
What this trial is testing

AT247, NovoRapid® and Fiasp® in Glucose Clamp Study

Who this might be right for
Diabetes Mellitus, Type 1
Arecor Limited 18
Early research (Phase 1)Study completedNCT03588923
What this trial is testing

Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of SH229 in Patients With HCV Infection

Who this might be right for
HCV Infection
Nanjing Sanhome Pharmaceutical, Co., Ltd. 30
Early research (Phase 1)Study completedNCT01292655
What this trial is testing

Study to Evaluate the Safety and Tolerability of IV Doses of BMS-906024 in Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Cancer
Bristol-Myers Squibb 94
Early research (Phase 1)Study completedNCT05186285
What this trial is testing

Single Ascending Dose Study of CM338 in Healthy Volunteers

Who this might be right for
Healthy
Keymed Biosciences Co.Ltd 66
Early research (Phase 1)Study completedNCT02616874
What this trial is testing

Study to Evaluate the Safety and Effect of HIVconsv Vaccines in Combination With Histone Deacetylase Inhibitor Romidepsin on the Viral Rebound Kinetic After Treatment Interruption in Early Treated HIV-1 Infected Individuals

Who this might be right for
HIV
IrsiCaixa 15
Early research (Phase 1)Study completedNCT05011097
What this trial is testing

A Phase I Clinical Trial of Y150 in the Treatment of Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Wuhan YZY Biopharma Co., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT00481520
What this trial is testing

Study Evaluating the Safety,Tolerability, PK and PD of SAM-531 in the Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Wyeth is now a wholly owned subsidiary of Pfizer 72
Testing effectiveness (Phase 2)Study completedNCT01284062
What this trial is testing

Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients

Who this might be right for
Colitis, Ulcerative
Pfizer 84
Early research (Phase 1)Study completedNCT00434746
What this trial is testing

Study of the Safety, Tolerability, PK, and PD of ILV-094 Administered IV or SC to Healthy Subjects

Who this might be right for
Healthy
Wyeth is now a wholly owned subsidiary of Pfizer 56
Next Page